BS, University of Iowa
MD, Albany Medical College
Medicine/Pediatrics Residency, Rush University Medical Center
Infectious Disease Fellowship, RUMC/CCH Combined fellowship
Oyedele is the principal Investigator for the Stroger/CORE Chicago Site of the Adolescent Medicine Trials Network (ATN) for HIV/AIDS interventions as well as site PI for HPTN (HIV Prevention Trials Network) 083 which is a Phase 2b/3 double blind safety and efficacy study of injectable Cabotegravir compared to daily Truvada for PrEP. He is also site Co-PI for the DISCOVER trial (comparing TDF to TAF for PrEP).
Areas of Expertise:
Adolescent HIV and PrEP